Patents by Inventor Moe Habib BISHARA
Moe Habib BISHARA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230149074Abstract: The subject of this disclosure is devices, systems, and uses thereof to treat a plurality of patients for paroxysmal atrial fibrillation. The solution can include delivering a multi-electrode radiofrequency balloon catheter and a multi-electrode diagnostic catheter to one or more targeted pulmonary veins; ablating tissue of the one or more targeted pulmonary veins using the multi-electrode radiofrequency balloon catheter; diagnosing the one or more targeted pulmonary veins using the multi-electrode diagnostic catheter; and achieving at least one of a predetermined clinical effectiveness and acute effectiveness of the method or use based on use of the multi-electrode radiofrequency balloon catheter and the multi-electrode diagnostic catheter in the isolation of the one or more targeted pulmonary veins.Type: ApplicationFiled: November 22, 2022Publication date: May 18, 2023Applicant: Biosense Webster (Israel) Ltd.Inventors: Moe Habib BISHARA, Nader GHALY, Kendra Anita MCINNIS, Assaf GOVARI, Christopher Thomas BEECKLER, Joseph Thomas KEYES, Rowan Olund HETTEL, Kevin Justin HERRERA
-
Patent number: 11534239Abstract: The subject of this disclosure is devices, systems, and uses thereof to treat a plurality of patients for paroxysmal atrial fibrillation. The solution can include delivering a multi-electrode radiofrequency balloon catheter and a multi-electrode diagnostic catheter to one or more targeted pulmonary veins; ablating tissue of the one or more targeted pulmonary veins using the multi-electrode radiofrequency balloon catheter; diagnosing the one or more targeted pulmonary veins using the multi-electrode diagnostic catheter; and achieving at least one of a predetermined clinical effectiveness and acute effectiveness of the method or use based on use of the multi-electrode radiofrequency balloon catheter and the multi-electrode diagnostic catheter in the isolation of the one or more targeted pulmonary veins.Type: GrantFiled: September 12, 2019Date of Patent: December 27, 2022Assignee: Biosense Webster (Israel) Ltd.Inventors: Moe Habib Bishara, Nader Ghaly, Kendra Anita Mcinnis, Assaf Govari, Christopher Thomas Beeckler, Joseph Thomas Keyes, Rowan Olund Hettel, Kevin Justin Herrera
-
Publication number: 20210330379Abstract: The subject of this disclosure includes an ablation system for visually supporting a tissue ablation procedure, including a display comprising a user interface; and at least one processor in communication with the display, the at least one processor configured to control one or more of a plurality of electrodes of a radiofrequency balloon catheter to ablate organ tissues of one or more targeted pulmonary veins; determine a characteristic, based on ablation parameters of the radiofrequency balloon catheter, of pulmonary vein isolation (PVI) success rate; and present, on the display, visual information corresponding to each electrode for an indication, based on the characteristic, for PVI success rate.Type: ApplicationFiled: July 8, 2021Publication date: October 28, 2021Applicant: Biosense Webster (Israel) Ltd.Inventors: Nader GHALY, Xiangming ZHANG, Eid ADAWI, Moe Habib BISHARA, Kendra Anita MCINNIS, Assaf GOVARI, Christopher Thomas BEECKLER, Joseph Thomas KEYES, Rowan Olund HETTEL, Kevin Justin HERRERA
-
Patent number: 11083520Abstract: The subject of this disclosure includes an apparatus for visually supporting a tissue ablation procedure, including a display comprising a user interface; and at least one processor in communication with the display, the at least one processor configured to control one or more of a plurality of electrodes of a radiofrequency balloon catheter to ablate organ tissues of one or more targeted pulmonary veins; determine a characteristic, based on ablation parameters of the radiofrequency balloon catheter, of pulmonary vein isolation (PVI) success rate; and present, on the display, visual information corresponding to each electrode for an indication, based on the characteristic, for PVI success rate.Type: GrantFiled: November 12, 2020Date of Patent: August 10, 2021Assignee: Biosense Webster (Israel) Ltd.Inventors: Nader Ghaly, Xiangming Zhang, Eid Adawi, Moe Habib Bishara, Kendra Anita McInnis, Assaf Govari, Christopher Thomas Beeckler, Joseph Thomas Keyes, Rowan Olund Hettel, Kevin Justin Herrera
-
Patent number: 11071585Abstract: The subject of this disclosure includes systems, devices and methods to treat a predetermined patient population for paroxysmal atrial fibrillation, the method including ablating tissue of one or more targeted pulmonary veins with one or more of a plurality of the electrodes of an independently controlled multi-electrode radiofrequency balloon catheter, the balloon catheter comprising the plurality of electrodes for radiofrequency ablation that are independently controllable; determining a predictor, based on ablation parameters of the balloon catheter, of single shot pulmonary vein isolation (PVI) success rate; and achieving, based on the predictor and step of ablating tissue, a single shot isolation PVI success rate in the isolation of all targeted pulmonary veins for the predetermined patient population.Type: GrantFiled: September 12, 2019Date of Patent: July 27, 2021Assignee: Biosense Webster (Israel) Ltd.Inventors: Xiangming Zhang, Nader Ghaly, Eid Adawi, Moe Habib Bishara, Kendra Anita McInnis, Assaf Govari, Christopher Thomas Beeckler, Joseph Thomas Keyes, Rowan Olund Hettel, Kevin Justin Herrera
-
Publication number: 20210059751Abstract: The subject of this disclosure includes an apparatus for visually supporting a tissue ablation procedure, including a display comprising a user interface; and at least one processor in communication with the display, the at least one processor configured to control one or more of a plurality of electrodes of a radiofrequency balloon catheter to ablate organ tissues of one or more targeted pulmonary veins; determine a characteristic, based on ablation parameters of the radiofrequency balloon catheter, of pulmonary vein isolation (PVI) success rate; and present, on the display, visual information corresponding to each electrode for an indication, based on the characteristic, for PVI success rate.Type: ApplicationFiled: November 12, 2020Publication date: March 4, 2021Inventors: Xiangming ZHANG, Nader GHALY, Eid ADAWI, Moe Habib BISHARA, Kendra Anita MCINNIS, Assaf GOVARI, Christopher Thomas BEECKLER, Joseph Thomas KEYES, Rowan Olund HETTEL, Kevin Justin HERRERA
-
Patent number: 10842562Abstract: The subject of this disclosure includes an apparatus for visually supporting a tissue ablation procedure, including a display comprising a user interface; and at least one processor in communication with the display, the at least one processor configured to control one or more of a plurality of electrodes of a radiofrequency balloon catheter to ablate organ tissues of one or more targeted pulmonary veins; determine a characteristic, based on ablation parameters of the radiofrequency balloon catheter, of pulmonary vein isolation (PVI) success rate; and present, on the display, visual information corresponding to each electrode for an indication, based on the characteristic, for PVI success rate.Type: GrantFiled: June 25, 2020Date of Patent: November 24, 2020Assignee: BIOSENSE WEBSTER (ISRAEL) LTD.Inventors: Xiangming Zhang, Nader Ghaly, Eid Adawi, Moe Habib Bishara, Kendra Anita McInnis, Assaf Govari, Christopher Thomas Beeckler, Joseph Thomas Keyes, Rowan Olund Hettel, Kevin Justin Herrera
-
Publication number: 20200323587Abstract: The subject of this disclosure includes an apparatus for visually supporting a tissue ablation procedure, including a display comprising a user interface; and at least one processor in communication with the display, the at least one processor configured to control one or more of a plurality of electrodes of a radiofrequency balloon catheter to ablate organ tissues of one or more targeted pulmonary veins; determine a characteristic, based on ablation parameters of the radiofrequency balloon catheter, of pulmonary vein isolation (PVI) success rate; and present, on the display, visual information corresponding to each electrode for an indication, based on the characteristic, for PVI success rate.Type: ApplicationFiled: June 25, 2020Publication date: October 15, 2020Applicant: Biosense Webster (Israel) Ltd.Inventors: Xiangming ZHANG, Nader GHALY, Eid ADAWI, Moe Habib BISHARA, Kendra Anita MCINNIS, Assaf GOVARI, Christopher Thomas BEECKLER, Joseph Thomas KEYES, Rowan Olund HETTEL, Kevin Justin HERRERA
-
Publication number: 20200085497Abstract: The subject of this disclosure includes systems, devices and methods to treat a predetermined patient population for paroxysmal atrial fibrillation, the method including ablating tissue of one or more targeted pulmonary veins with one or more of a plurality of the electrodes of an independently controlled multi-electrode radiofrequency balloon catheter, the balloon catheter comprising the plurality of electrodes for radiofrequency ablation that are independently controllable; determining a predictor, based on ablation parameters of the balloon catheter, of single shot pulmonary vein isolation (PVI) success rate; and achieving, based on the predictor and step of ablating tissue, a single shot isolation PVI success rate in the isolation of all targeted pulmonary veins for the predetermined patient population.Type: ApplicationFiled: September 12, 2019Publication date: March 19, 2020Applicant: Biosense Webster (Israel) Ltd.Inventors: Xiangming ZHANG, Nader GHALY, Eid ADAWI, Moe Habib BISHARA, Kendra Anita MCINNIS, Assaf GOVARI, Christopher Thomas BEECKLER, Joseph Thomas KEYES, Rowan Olund HETTEL, Kevin Justin HERRERA
-
Publication number: 20200046422Abstract: The subject of this disclosure is devices, systems, and uses thereof to treat a plurality of patients for paroxysmal atrial fibrillation. The solution can include delivering a multi-electrode radiofrequency balloon catheter and a multi-electrode diagnostic catheter to one or more targeted pulmonary veins; ablating tissue of the one or more targeted pulmonary veins using the multi-electrode radiofrequency balloon catheter; diagnosing the one or more targeted pulmonary veins using the multi-electrode diagnostic catheter; and achieving at least one of a predetermined clinical effectiveness and acute effectiveness of the method or use based on use of the multi-electrode radiofrequency balloon catheter and the multi-electrode diagnostic catheter in the isolation of the one or more targeted pulmonary veins.Type: ApplicationFiled: September 12, 2019Publication date: February 13, 2020Applicant: Biosense Webster (Israel) Ltd.Inventors: Moe Habib BISHARA, Nader GHALY, Kendra Anita MCINNIS, Assaf GOVARI, Christoper Thomas BEECKLER, Joseph Thomas KEYES, Rowan Olund HETTEL, Kevin Justin HERRERA